124 related articles for article (PubMed ID: 21804399)
1. Aggressive angiomyxoma [corrected] of the female genital tract and pelvis--clinicopathologic features with immunohistochemical analysis.
Bigby SM; Symmans PJ; Miller MV; Dray MS; Jones RW
Int J Gynecol Pathol; 2011 Sep; 30(5):505-13. PubMed ID: 21804399
[TBL] [Abstract][Full Text] [Related]
2. Aggressive angiomyxoma of male genital region. Report of 4 cases with immunohistochemical evaluation including hormone receptor status.
Idrees MT; Hoch BL; Wang BY; Unger PD
Ann Diagn Pathol; 2006 Aug; 10(4):197-204. PubMed ID: 16844560
[TBL] [Abstract][Full Text] [Related]
3. HMGA2 is a sensitive but not specific immunohistochemical marker of vulvovaginal aggressive angiomyxoma.
McCluggage WG; Connolly L; McBride HA
Am J Surg Pathol; 2010 Jul; 34(7):1037-42. PubMed ID: 20551826
[TBL] [Abstract][Full Text] [Related]
4. Individualized managing strategies of aggressive angiomyxoma of female genital tract and pelvis.
Bai HM; Yang JX; Huang HF; Cao DY; Chen J; Yang N; Lang JH; Shen K
Eur J Surg Oncol; 2013 Oct; 39(10):1101-8. PubMed ID: 23899874
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic analysis of aggressive angiomyxoma in the pelvis and vulva of 8 cases].
Liao Q; Liu Z; Zhang Y; He Q
Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):359-62. PubMed ID: 12126573
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in vulvovaginal pathology.
McCluggage WG
Histopathology; 2009 Jan; 54(2):156-73. PubMed ID: 18637148
[TBL] [Abstract][Full Text] [Related]
7. Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up.
van Roggen JF; van Unnik JA; Briaire-de Bruijn IH; Hogendoorn PC
Virchows Arch; 2005 Feb; 446(2):157-63. PubMed ID: 15735978
[TBL] [Abstract][Full Text] [Related]
8. Aggressive angiomyxoma: a case series and literature review.
Haldar K; Martinek IE; Kehoe S
Eur J Surg Oncol; 2010 Apr; 36(4):335-9. PubMed ID: 19954923
[TBL] [Abstract][Full Text] [Related]
9. Aggressive angiomyxoma.
Sutton BJ; Laudadio J
Arch Pathol Lab Med; 2012 Feb; 136(2):217-21. PubMed ID: 22288973
[TBL] [Abstract][Full Text] [Related]
10. Aggressive angiomyxoma: a clinicopathologic study of 29 female patients.
Fetsch JF; Laskin WB; Lefkowitz M; Kindblom LG; Meis-Kindblom JM
Cancer; 1996 Jul; 78(1):79-90. PubMed ID: 8646730
[TBL] [Abstract][Full Text] [Related]
11. Frequency and characterization of HMGA2 and HMGA1 rearrangements in mesenchymal tumors of the lower genital tract.
Medeiros F; Erickson-Johnson MR; Keeney GL; Clayton AC; Nascimento AG; Wang X; Oliveira AM
Genes Chromosomes Cancer; 2007 Nov; 46(11):981-90. PubMed ID: 17654722
[TBL] [Abstract][Full Text] [Related]
12. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma.
Rabban JT; Dal Cin P; Oliva E
Int J Gynecol Pathol; 2006 Oct; 25(4):403-7. PubMed ID: 16990720
[TBL] [Abstract][Full Text] [Related]
13. Superficial cervicovaginal myofibroblastoma: fourteen cases of a distinctive mesenchymal tumor arising from the specialized subepithelial stroma of the lower female genital tract.
Laskin WB; Fetsch JF; Tavassoli FA
Hum Pathol; 2001 Jul; 32(7):715-25. PubMed ID: 11486170
[TBL] [Abstract][Full Text] [Related]
14. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
15. Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors.
Sung CO; Ahn G; Song SY; Choi YL; Bae DS
Int J Gynecol Pathol; 2009 Nov; 28(6):529-34. PubMed ID: 19851199
[TBL] [Abstract][Full Text] [Related]
16. Aggressive angiomyxoma of the vulva: Dramatic response to gonadotropin-releasing hormone agonist therapy.
McCluggage WG; Jamieson T; Dobbs SP; Grey A
Gynecol Oncol; 2006 Mar; 100(3):623-5. PubMed ID: 16246403
[TBL] [Abstract][Full Text] [Related]
17. HMGA2 Is a Useful Marker of Vulvovaginal Aggressive Angiomyxoma But May Be Positive in Other Mesenchymal Lesions at This Site.
Harkness R; McCluggage WG
Int J Gynecol Pathol; 2021 Mar; 40(2):185-189. PubMed ID: 32897956
[TBL] [Abstract][Full Text] [Related]
18. Benign cystic mesothelioma of the peritoneum: a clinicopathologic study of 17 cases and immunohistochemical analysis of estrogen and progesterone receptor status.
Sawh RN; Malpica A; Deavers MT; Liu J; Silva EG
Hum Pathol; 2003 Apr; 34(4):369-74. PubMed ID: 12733118
[TBL] [Abstract][Full Text] [Related]
19. Aggressive angiomyxoma of the female pelvis and perineum: a case series.
Magtibay PM; Salmon Z; Keeney GL; Podratz KC
Int J Gynecol Cancer; 2006; 16(1):396-401. PubMed ID: 16445665
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression in postmastectomy chest wall relapse.
Kim JH; Bossuyt V; Ponn T; Lannin D; Haffty BG
Clin Cancer Res; 2005 Jul; 11(14):5199-205. PubMed ID: 16033837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
